- Global Pharma News & Resources

Dublin-based start-up launch Wirano – a global digital platform for organizing clinical trials

Dublin, Ireland – 22 October 2020 – Life Science Newswire – A Dublin-based tech start-up today announced the launch of Wirano – a digital platform for the rapid and effective organization of clinical trials. The platform aims to revolutionize the activities involved in clinical trials by accelerating start-up of trials, optimizing patient recruitment, and improving site and investigator selection processes.


“The enormous cost of clinical trials in terms of time, money and effort is well known. The average clinical trial process lasts between 7.5 and 12 years with costs ranging from $161M - $2.6B per drug. Yet in spite of this investment, the success rate of clinical trials is just 14% (1),” said Noel Quinn, Commercial Director, “Wirano aims to improve this rate of success by optimizing the patient recruitment process, improving site selection procedures and creating reliable channels for effective communications between all participants.”


One of the major challenges is searching for and selecting patients for trials – which is why 50% of all planned trials do not achieve recruitment targets on time. In fact, up to 11% of all trials do not recruit a single patient. In addition, the organizers of clinical trials often find it difficult to select a research center with reliable data on previous experience and patient enrollment. The lack of a single database of centers from different countries and the absence of effective and reliable communication channels with research teams further aggravate the situation. Wirano is designed to allow all participants of clinical trials, including pharmaceutical companies, medical researchers, and patients to effectively communicate throughout the process.


Wirano will significantly optimize the process as pharmaceutical companies (sponsors) will be able to quickly select research teams in different countries, doctors will be able to quickly post information about clinical trials for patients and start recruiting, and patients will have the possibility of finding a suitable clinical trial in a matter of minutes and apply for participation in it.


Wirano is the brainchild of a team of international experts in the area of clinical research and is based in Dublin. The project has completed pre-seed financing and is currently seeking investors to fully realize the revolutionary power of its platform. Find out more by visiting


For more information:
Nicola Donnelly
M: 00 353 (0) 83 8579080


About Wirano


Wirano is a cloud technology platform that optimizes the organization of clinical trials. It combines the personal accounts of patients, medical researchers and representatives of pharmaceutical companies, and contract research organizations. The accounts will be available as mobile applications and web versions.


The project was created by an international team with over 20 years of experience in clinical research. The founders of the project have also participated in the creation of a number of international projects, including the contract research organization (CRO) Cromos Pharma and the clinical research logistics company COREX Logistics, which are among the leaders on the markets of the CIS and Eastern Europe.


The project has already passed the pre-seed stage of financing by the team itself and is in search of start-up investors.


At present, the architecture of the project has been fully designed and basic modules have been created that are in the process of being tested. Two international patents for key user interfaces have also been received. Another nine patents are to be obtained in 2021.


The company plans to launch a module for patients and create a corresponding database by the end of the year 2020. The first sponsors and research centers are to be connected in 2021. The next step will be scaling and entry onto global markets.


[1] MIT

Editor Details

Last Updated: 23-Oct-2020